Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUGDENT: Amoxicillin/Clavulanate vs Clindamycin for Acute Odontogenic Infection
NCT02141217Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, single-blind trial of amoxicillin + clavulanate in acute odontogenic infection (OI) (2 arms), sponsored by GSK. Primary endpoint: Percentage of Participants Achieving Clinical Success (Cure or Improvement) Considering Clinical Judgment of the Investigator at Day 7. Started Mar 2013; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
acute odontogenic infection (OI)
Beyond the preview
Go deeper on NCT02141217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141217.